Eight years and $1.3B later, AstraZeneca finally unveils Cambridge R&D palace

One of the biggest projects that Pascal Soriot initiated, all the way back in 2013, after he first took over as AstraZeneca’s CEO is finally complete.

Pascal Soriot

AstraZeneca is formally unveiling its $1.34 billion (£1 billion) R&D campus in Cambridge, UK, a shiny new facility...

Click to view original post